Effect of Government Shutdown on Rare Disease Research
The government shutdown hasn't had any startling affects on rare disease research yet, but drug developers have voiced their concern that it could soon begin to hinder the research process.…
Disparities in Cancer Care Addressed by the NCCN
"People always say that 'cancer doesn't discriminate,' but the healthcare system often does," -Liz Margolies, LCSW, Executive Director, National LGBT Cancer Network. Unfortunately, the reality of this statement is that there…
Research Updates for Multiple Myeloma and WM!
Dana-Farber Cancer Institute has just announced research updates on multiple myeloma and waldenstrom macroglobulinemia which indicate significant progress in the search for treatments for these diseases. The Findings 1) There…
<a href="https://pixabay.com/users/crystal710/">crystal710</a> / Pixabay
Recent Clinical Trials Highlight Potential of Targeted Therapies for Multiple Myeloma and Chronic Lymphocytic Leukemia
According to a story from PR Newswire, the 60th Annual Meeting of the American Society of Hematology has been generating a lot of press lately as many groundbreaking studies, research,…
<a href="https://pixabay.com/users/mwooten/">mwooten</a> / Pixabay
Enrollment is Complete for Trial of Experimental Multiple Myeloma Treatment
According to a story from BioPortfolio, Celgene Corporation and bluebird bio, Inc., have recently announced that enrollment for a pivotal Phase 2 study testing an experimental therapy for relapsed/refractory multiple…
Working to Improve Gene Therapy for Adrenoleukodystrophy and Other Rare Conditions
Rare disease research is often underrepresented in the field of science. However, recent developments have made researchers more interested in studying this group of diseases. For instance, investments in gene…
source: pixabay.com
Rare Cancer Treatment Updates From the FDA
According to a story from The Oncology Times, the US Food and Drug Administration (FDA) has been moving forward with several treatments and potential treatments for a variety of different…
source: pixabay.com
CAR-T Cell Therapy Earns Regenerative Medicine Advanced Therapy Designation for Multiple Myeloma
According to a story from Hematology Times, an experimental CAR-T cell therapy called P-BCMA-101 was recently granted regenerative medicine advanced therapy (RMAT) designation from the US Food and Drug Administration.…
<a href="https://pixabay.com/users/allinonemovie/">allinonemovie</a> / Pixabay
Rare Blood Cancer Trial Data to be Presented in Upcoming Conference
According to a story from investors.amgen.com, the drug developer Amgen recently announced its intent to present all new clinical trial data which will feature its latest work in testing a…
<a href="https://pixabay.com/users/rawpixel/">rawpixel</a> / Pixabay
Selinexor Gets Priority Review From the FDA for Multiple Myeloma
According to a story from OncLive, the drug development company Karyopharm Therapeutics recently announced that the US Food and Drug Administration has granted Priority Review to the company's XPO1 inhibitor…
<a href="https://pixabay.com/users/Pexels/">Pexels</a> / Pixabay
Clinical Trials For Multiple Myeloma and Other Diseases Fail to Reflect Racial Demographics
According to a story from Mother Jones, patients of black or Native American backgrounds are consistently underrepresented in clinical trials. This occurs even when the trials are for diseases that…
Make Blood Cancer Visible Campaign Raises Awareness for Multiple Myeloma
According to a report by the Irish Examiner, one in three people spend at least 45 hours or more caring for a someone living with cancer. Despite this being a…
<a href="https://pixabay.com/users/jarmoluk/">jarmoluk</a> / Pixabay
Researchers Have Found Which Common Blood Tests are the Most Effective for Identifying Multiple Myeloma
A team of researchers led by Constantinos Koshiaris from the University of Oxford have recently published a study that investigated the best way to identify multiple myeloma through blood tests.…
Scientist from USC is Designing a New Tool to Personalize Care for Cancer Patients and Guide Treatment
According to a story from HSC News, Dr. Peter Kuhn from the University of South Carolina (USC) is developing a navigational tool that aims to personalize treatment based on a…
Taking a Swing at Multiple Myeloma: Amgen Partners with MLB Stars
What do Dave Winfield, Steve Garvey, and Don Baylor Jr. all have in common? Besides all being big names in major league baseball, each of the famous athletes is contributing…
NCCN Tailors Mutiple Myeloma Treatment for Caribbean
As vice chair of the National Comprehensive Cancer Network ‘s (NCCN) committee on multiple myeloma, Dr. Natalie Callander helps to set guidelines for effective evaluation and treatment. The NCCN commonly…
<a href="https://pixabay.com/users/PublicDomainPictures/">PublicDomainPictures</a> / Pixabay
ICYMI: Researchers Develop a New Immunotherapy Technique Using Electric Shocks
According to a story from the Washington Post, a new technique for delivering genes into immune system T cells could make immunotherapy a much more accessible option for treating rare…
Research Shows Shocking Technique for Gene-Editing Therapies
Gene-editing therapies have made almost constant news headlines in relations to cancer treatment. The process of reprogramming the body’s immune cells to fight cancer seems more and more promising. The…
<a href="https://pixabay.com/users/fernandozhiminaicela/">fernandozhiminaicela</a> / Pixabay
Melflufen Could be a New Treatment Option for Multiple Myeloma
According to a story from Hematology Times, a medicine called melflufen, of the alkylating peptide class, appears to be effective in treatment resistant multiple myeloma. In a Phase 2 trial,…
<a href="https://pixabay.com/users/PDPics/">PDPics</a> / Pixabay
Multiple Myeloma Survivor Isn’t Stopping the Search For a Cure
According to a story from Deseret News, after she was diagnosed with multiple myeloma, Jenny Ahlstrom almost immediately had to make crucial decisions regarding her treatment: decisions that could mean…
<a href="https://pixabay.com/users/jarmoluk/">jarmoluk</a> / Pixabay
This Drug Company is Hoping to Lead The Next Generation of Cancer Treatments
According to uk.reuters.com, the pharmaceutical company Sanofi is playing catch up to put itself ahead of the competition in developing the new cancer treatments. The French company didn't join in…
Film Star Lisa Ray Shares Her Experience with Multiple Myeloma
Lisa Ray starred in the 2005 film Water. She also appeared in TV shows such as Endgame, Psych, and Top Chef Canada. Now, as an advocate for people with multiple…
Novel Multiple Myeloma Treatment Granted Orphan Drug Designation
According to Globe Newswire, the United States Food and Drug Administration (US FDA) designated a new orphan drug for the treatment of multiple myeloma on May 9th, 2018. The drug…
<a href="https://pixabay.com/users/Clker-Free-Vector-Images/">Clker-Free-Vector-Images</a> / Pixabay
Genmab, Johnson and Johnson’s Trial of Darzalex in Solid Tumors is Cancelled
According to a story from Reuters, the Danish biotech company Genmab saw its share value drop by a quarter after Johnson & Johnson, which had partnered with the company to…
A Drug For Multiple Myeloma has Been Approved by the FDA
The U.S. Food and Drug Administration (FDA) has just approved a drug called Darzalex (daratumumab) in combination with the drug Velcade (bortezomib), melphalan, and prednisone (known collectively as VMP) for…
